1-2 of 2
Roger M. LeBlanc, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

R-Nanochop Incorporating a TFR1-Targeted Doxorubicin Nanocarrier Is Superior to R-CHOP in a PDX Model of Diffuse Large B-Cell Lymphoma

Artavazd Arumov, BSc, Piumi Y. Liyanage, PhD, Asaad Trabolsi, MD, Evan R. Roberts, BS, Braulio C. L. B. Ferreira, BS, Austin D. Newsam, BS, Daniel Bilbao, PhD, Roger M. Leblanc, PhD, Jonathan H. Schatz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43.
https://doi.org/10.1182/blood-2020-133482
Published: 2020
Journal Articles

Targeted Delivery of Nanocarrier-Conjugated Doxorubicin to Widen the Therapeutic Window of the Most Active Drug in Lymphoma Therapeutics

Artavazd Arumov, BSc, Piumi Y. Liyanage, BS, Asaad Trabolsi, MD, Lingxiao Li, PhD, Evan R. Roberts, BS, Daniel Bilbao, PhD, Roger M. LeBlanc, PhD, Jonathan H. Schatz, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4061.
https://doi.org/10.1182/blood-2019-122599
Published: 2019